Core Scientific (CORZ) Cost of Revenue (2021 - 2026)
Core Scientific has reported Cost of Revenue over the past 6 years, most recently at $85.1 million for Q1 2026.
- Quarterly results put Cost of Revenue at $85.1 million for Q1 2026, up 19.39% from a year ago — trailing twelve months through Mar 2026 was $294.9 million (down 17.9% YoY), and the annual figure for FY2025 was $281.1 million, down 27.84%.
- Cost of Revenue reached $85.1 million in Q1 2026 per CORZ's latest filing, up from $59.0 million in the prior quarter.
- Across five years, Cost of Revenue topped out at $375.8 million in Q4 2023 and bottomed at -$450.7 million in Q4 2022.
- Median Cost of Revenue over the past 5 years was $77.2 million (2025), compared with a mean of $57.3 million.
- The largest annual shift saw Cost of Revenue tumbled 219.34% in 2022 before it soared 9335.89% in 2024.
- Over 5 years, Cost of Revenue stood at -$450.7 million in 2022, then skyrocketed by 183.39% to $375.8 million in 2023, then crashed by 76.01% to $90.2 million in 2024, then tumbled by 34.55% to $59.0 million in 2025, then surged by 44.28% to $85.1 million in 2026.
- Business Quant data shows Cost of Revenue for CORZ at $85.1 million in Q1 2026, $59.0 million in Q4 2025, and $77.2 million in Q3 2025.